相关实验视频
Updated: Jun 5, 2026

16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
20.6K
一个随机试验,比较Imlifidase与移植在移植接受者与抗体介导的排斥
Fabian Halleck1,2, Georg A Böhmig3, Lionel Couzi4,5
1Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Clinical transplantation
|July 18, 2024
概括
伊姆利菲达斯在移植患者中有效降低了捐赠者特异性抗体 (DSA),但没有显示出与抗体介导排斥 (ABMR) 治疗性血交换 (PLEX) 相比的明显临床益处. 需要进一步的研究来澄清其在改善长期移植存活中的作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 抗体介导排斥 (ABMR) 是对长期移植存活的重大挑战.
- 治疗性血交换 (PLEX) 用于抗体耗尽,但有效性有变化.
- 伊姆利菲达斯提供了快速和几乎完全的捐赠者特异性抗体 (DSA) 失活.
研究的目的:
- 为了比较imlifidase与PLEX在降低ABMR患者的DSA水平方面的疗效.
- 评估imlifidase治疗在这个人群中的安全性和临床结果.
主要方法:
- 一个为期6个月的随机化,开放式,多中心试验,涉及30名ABMR患者.
- 患者被随机分配,接受imlifidase或PLEX.
- 主要终点是治疗开始后5天内DSA水平的降低.
主要成果:
- 与PLEX的42%,相比之下,Imlifidase实现了97%的DSA减少,满足了主要终点.
- 与PLEX.不同的是,伊米利菲达酶将DSA降低到非补充固定水平,不像PLEX.
- 尽管最初的DSA减少,但imlifidase在6个月后显示了较低的移植存活率 (78%) 与PLEX (89%) 相比,imlifidase手臂有4个全移植损失.
- 不良事件在各组之间是相似的.
结论:
- 伊米利菲达斯在ABMR治疗中是安全和耐受的.
- 虽然imlifidase有效地降低了DSA,但与PLEX相比,它在这个异质ABMR群体中没有改善临床结果或移植存活率.
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

